A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Michael Rose
Michael Rose
Rosalio Madrigal
| Share Statistics | NEO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,040.2 | $1,875.0 | 54% |
|
| Shares Out (Mil) | 130.8 | 77.1 | 68% |
|
| Institutional Ownership | 97.9% | 88.9% | 76% |
|
| Float (Mil) | 118.3 | 50.3 | 65% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 3,793 | 466 | 90% |
|
| Price Change (52-week) |
202.5% | 78.5% | 97% |
|
| Growth | NEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.4% | 10.9% | 60% |
|
| Net Income (5yr) | (94.3%) | (1.1%) | 2% |
|
| EPS (5yr) | (89.1%) | 3.0% | 1 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (33.8%) | (18.2%) | 16% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 11 | 11 | |
| Current EPS | $0.054 | $0.183 | $0.338 | |
| Month Ago EPS | $0.056 | $0.183 | $0.365 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 1 | 0 | 3 | |
| Three Months Ago EPS | $0.056 | $0.183 | $0.365 | |
| Year/Year Chg | 217.6% | (121.7%) | (155.5%) | |
| Financials | NEO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $766 | $1,464 | 47% |
|
| Net Income (TTM) (Mil) | ($52) | $15 | 16% |
|
| EPS (TTM) | ($0.402) | $0.300 | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $22 | $138 | 42% |
|
| Net Cash Flow (TTM) (Mil) | ($9) | $7 | 31% |
|
| Long-Term Debt (Q1) (Mil) | $443 | $323 | 58% |
|
| Enterprise Value (Q1) (Mil) | $2,048 | $2,130 | 50% |
|
| Valuation | NEO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.59 | 2.90 | 60% |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | NEO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 43.9% | 27.6% | 55% |
|
| Net Margin | (6.8%) | 1.1% | 23% |
|
| ROA | (3.8%) | 1.8% | 31% |
|
| ROE | (6.3%) | 6.9% | 30% |
|
| Liabilities to Assets | 41.9% | 60.0% | 33% |
|
| F-Score | 5 | 5 | 51% |
|
NeoGenomics, Inc. did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
